US FDA accepts for review Berkshire Biomedical’s De Novo application for marketing authorization of COPA System: Dallas, Texas Tuesday, July 8, 2025, 15:00 Hrs [IST] Berkshire B ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

Senators will have the Capitol to themselves when they return Tuesday for an abbreviated work week, with several items on the ...